Yersinia type III effectors perturb host innate immune responses.

Khavong Pha, Lorena Navarro
{"title":"Yersinia type III effectors perturb host innate immune responses.","authors":"Khavong Pha, Lorena Navarro","doi":"10.4331/wjbc.v7.i1.1","DOIUrl":null,"url":null,"abstract":"The innate immune system is the first line of defense against invading pathogens. Innate immune cells recognize molecular patterns from the pathogen and mount a response to resolve the infection. The production of proinflammatory cytokines and reactive oxygen species, phagocytosis, and induced programmed cell death are processes initiated by innate immune cells in order to combat invading pathogens. However, pathogens have evolved various virulence mechanisms to subvert these responses. One strategy utilized by Gram-negative bacterial pathogens is the deployment of a complex machine termed the type III secretion system (T3SS). The T3SS is composed of a syringe-like needle structure and the effector proteins that are injected directly into a target host cell to disrupt a cellular response. The three human pathogenic Yersinia spp. (Y. pestis, Y. enterocolitica, and Y. pseudotuberculosis) are Gram-negative bacteria that share in common a 70 kb virulence plasmid which encodes the T3SS. Translocation of the Yersinia effector proteins (YopE, YopH, YopT, YopM, YpkA/YopO, and YopP/J) into the target host cell results in disruption of the actin cytoskeleton to inhibit phagocytosis, downregulation of proinflammatory cytokine/chemokine production, and induction of cellular apoptosis of the target cell. Over the past 25 years, studies on the Yersinia effector proteins have unveiled tremendous knowledge of how the effectors enhance Yersinia virulence. Recently, the long awaited crystal structure of YpkA has been solved providing further insights into the activation of the YpkA kinase domain. Multisite autophosphorylation by YpkA to activate its kinase domain was also shown and postulated to serve as a mechanism to bypass regulation by host phosphatases. In addition, novel Yersinia effector protein targets, such as caspase-1, and signaling pathways including activation of the inflammasome were identified. In this review, we summarize the recent discoveries made on Yersinia effector proteins and their contribution to Yersinia pathogenesis.","PeriodicalId":23691,"journal":{"name":"World journal of biological chemistry","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"40","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of biological chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4331/wjbc.v7.i1.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 40

Abstract

The innate immune system is the first line of defense against invading pathogens. Innate immune cells recognize molecular patterns from the pathogen and mount a response to resolve the infection. The production of proinflammatory cytokines and reactive oxygen species, phagocytosis, and induced programmed cell death are processes initiated by innate immune cells in order to combat invading pathogens. However, pathogens have evolved various virulence mechanisms to subvert these responses. One strategy utilized by Gram-negative bacterial pathogens is the deployment of a complex machine termed the type III secretion system (T3SS). The T3SS is composed of a syringe-like needle structure and the effector proteins that are injected directly into a target host cell to disrupt a cellular response. The three human pathogenic Yersinia spp. (Y. pestis, Y. enterocolitica, and Y. pseudotuberculosis) are Gram-negative bacteria that share in common a 70 kb virulence plasmid which encodes the T3SS. Translocation of the Yersinia effector proteins (YopE, YopH, YopT, YopM, YpkA/YopO, and YopP/J) into the target host cell results in disruption of the actin cytoskeleton to inhibit phagocytosis, downregulation of proinflammatory cytokine/chemokine production, and induction of cellular apoptosis of the target cell. Over the past 25 years, studies on the Yersinia effector proteins have unveiled tremendous knowledge of how the effectors enhance Yersinia virulence. Recently, the long awaited crystal structure of YpkA has been solved providing further insights into the activation of the YpkA kinase domain. Multisite autophosphorylation by YpkA to activate its kinase domain was also shown and postulated to serve as a mechanism to bypass regulation by host phosphatases. In addition, novel Yersinia effector protein targets, such as caspase-1, and signaling pathways including activation of the inflammasome were identified. In this review, we summarize the recent discoveries made on Yersinia effector proteins and their contribution to Yersinia pathogenesis.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
III型耶尔森菌效应物扰乱宿主先天免疫反应。
先天免疫系统是抵御病原体入侵的第一道防线。先天免疫细胞识别来自病原体的分子模式,并产生应答以解决感染。促炎细胞因子和活性氧的产生、吞噬和诱导的程序性细胞死亡是先天免疫细胞为了对抗入侵的病原体而启动的过程。然而,病原体已经进化出各种毒力机制来破坏这些反应。革兰氏阴性细菌病原体采用的一种策略是部署称为III型分泌系统(T3SS)的复杂机器。T3SS由类似注射器的针状结构和效应蛋白组成,这些效应蛋白被直接注射到目标宿主细胞中以破坏细胞反应。三种人类致病性耶尔森氏菌(鼠疫耶尔森氏菌、小肠结肠炎耶尔森氏菌和假结核耶尔森氏菌)是革兰氏阴性菌,它们共有一个70kb的毒力质粒,编码T3SS。耶尔森氏菌效应蛋白(YopE、YopH、YopT、YopM、YpkA/YopO和YopP/J)易位到靶宿主细胞后,可破坏肌动蛋白细胞骨架,抑制吞噬,下调促炎细胞因子/趋化因子的产生,诱导靶细胞凋亡。在过去的25年里,对耶尔森氏菌效应蛋白的研究揭示了效应蛋白如何增强耶尔森氏菌的毒力。最近,人们期待已久的YpkA晶体结构已经得到解决,为YpkA激酶结构域的激活提供了进一步的见解。YpkA激活其激酶结构域的多位点自磷酸化也被证明是一种绕过宿主磷酸酶调节的机制。此外,还发现了新的耶尔森菌效应蛋白靶点,如caspase-1,以及包括炎症小体激活在内的信号通路。本文综述了近年来有关耶尔森氏菌效应蛋白的研究进展及其在耶尔森氏菌发病机制中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Hmo1: A versatile member of the high mobility group box family of chromosomal architecture proteins Hmo1: A versatile member of the high mobility group box family of chromosomal architecture proteins In silico evidence of Remdesivir action in blood coagulation cascade modulation in COVID-19 treatment. Comparison of the conventional tube and erythrocyte-magnetized technology in titration of red blood cell alloantibodies. Molecular genetics of early-onset colorectal cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1